Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  28 results for ""Non-Muscle Invasive Bladder Neoplasms""

Your Filters

Publication : european urology
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Proteogenomic Characterization of Bladder Cancer Reveals Sensitivity to Apoptosis Induced by Tumor Necrosis Factor-related Apoptosis-inducing Ligand in FGFR3-mutated Tumors.

  • Authors : Groeneveld CS; Equipe labellisée Ligue Contre le Cancer, CNRS, UMR144, Institut Curie, PSL Research University, Paris, France; Centre de Recherche des Cordeliers, AP-HP, Université Paris Cité, Paris, France.

Subjects: Non-Muscle Invasive Bladder Neoplasms*/Non-Muscle Invasive Bladder Neoplasms*/Non-Muscle Invasive Bladder Neoplasms*/drug therapy ; Non-Muscle Invasive Bladder Neoplasms*/Non-Muscle Invasive Bladder Neoplasms*/Non-Muscle Invasive Bladder Neoplasms*/genetics ; Non-Muscle Invasive Bladder Neoplasms*/Non-Muscle Invasive Bladder Neoplasms*/Non-Muscle Invasive Bladder Neoplasms*/pathology

  • Source: European urology [Eur Urol] 2024 May; Vol. 85 (5), pp. 483-494. Date of Electronic Publication: 2023 Jun 27.Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

A 23-Gene Prognostic Index Predicts Progression and Bacillus Calmette-Guérin Response in Non-muscle-invasive Bladder Cancer.

  • Authors : Kim SK; Aging Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea; Department of Bioscience, University of Science and Technology, Daejeon, Republic of Korea

Subjects: Non-Muscle Invasive Bladder Neoplasms* ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/genetics ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/drug therapy

  • Source: European urology [Eur Urol] 2024 Apr; Vol. 85 (4), pp. 400-402. Date of Electronic Publication: 2024 Jan 11.Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Re: Rakesh Heer, Rebecca Lewis, Thenmalar Vadiveloo, et al. A Randomized Trial of PHOTOdynamic Surgery in Non-muscle-invasive Bladder Cancer. NEJM Evid 2022;1:EVIDoa2200092.

  • Authors : Sussman J; Department of Urology, University of Minnesota, Minneapolis, MN, USA.; Konety B

Subjects: Non-Muscle Invasive Bladder Neoplasms* ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/drug therapy ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/surgery

  • Source: European urology [Eur Urol] 2024 Feb; Vol. 85 (2), pp. 178-179. Date of Electronic Publication: 2023 Aug 12.Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer.

  • Authors : Strandgaard T; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Subjects: Non-Muscle Invasive Bladder Neoplasms* ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/therapy ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/drug therapy

  • Source: European urology [Eur Urol] 2024 Jan; Vol. 85 (1), pp. 82-92. Date of Electronic Publication: 2023 Sep 16.Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

SWOG S1605: Moving Beyond Systemic Immune Checkpoint Inhibitor Monotherapy in Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer.

  • Authors : Kulkarni GS; Division of Urology and Surgical Oncology, Department of Surgery, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. Electronic address: .; Wettstein MS

Subjects: Non-Muscle Invasive Bladder Neoplasms* ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/drug therapy; Humans

  • Source: European urology [Eur Urol] 2023 Dec; Vol. 84 (6), pp. 545-546. Date of Electronic Publication: 2023 Oct 04.Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin-unresponsive High-risk Non-muscle-invasive Bladder Cancer: SWOG S1605.

  • Authors : Black PC; University of British Columbia, Vancouver, Canada. Electronic address: .; Tangen CM

Subjects: Non-Muscle Invasive Bladder Neoplasms* ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/pathology ; Carcinoma in Situ*/Carcinoma in Situ*/Carcinoma in Situ*/pathology

  • Source: European urology [Eur Urol] 2023 Dec; Vol. 84 (6), pp. 536-544. Date of Electronic Publication: 2023 Aug 16.Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Report

A Step Closer to Predicting Progression After Bacillus Calmette-Guérin Immunotherapy in High-risk Non-muscle-invasive Bladder Cancer.

  • Authors : Koti M; Department of Biomedical and Molecular Sciences, Department of Urology, Cancer Research Institute, Queen's University, Kingston, ON, Canada. Electronic address: .; Robert Siemens D

Subjects: Non-Muscle Invasive Bladder Neoplasms* ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/drug therapy ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/genetics

  • Source: European urology [Eur Urol] 2023 Nov; Vol. 84 (5), pp. 447-448. Date of Electronic Publication: 2023 Jul 01.Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

First-line Intravesical Chemotherapy for Non-muscle-invasive Bladder Cancer: Chimera or "Ne Plus Ultra"?

  • Authors : Lenfant L; Sorbonne University, GRC 5, Predictive Onco-urology, Department of Urology, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France. Electronic address: .; Pinar U

Subjects: Non-Muscle Invasive Bladder Neoplasms* ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/drug therapy ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/surgery

  • Source: European urology [Eur Urol] 2023 Jul; Vol. 84 (1), pp. 1-3. Date of Electronic Publication: 2023 Mar 21.Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Re: Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial.

  • Authors : Paolo G; Division of Urology, Department of Surgical Sciences, AOU Città della Salute e della Scienza di Torino, Torino School of Medicine, Torino, Italy. Electronic address: .; Francesco S

Subjects: Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/drug therapy ; Non-Muscle Invasive Bladder Neoplasms*; Humans

  • Source: European urology [Eur Urol] 2023 Jun; Vol. 83 (6), pp. 580. Date of Electronic Publication: 2023 Jan 27.Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Re: IL-15 Superagonist NAI in BCG-Unresponsive Non-muscle-invasive Bladder Cancer.

  • Authors : Suderman J; Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. Electronic address: .; St-Laurent MP

Subjects: Non-Muscle Invasive Bladder Neoplasms* ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/drug therapy; Humans

  • Source: European urology [Eur Urol] 2023 Jun; Vol. 83 (6), pp. 581. Date of Electronic Publication: 2023 Feb 01.Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  28 results for ""Non-Muscle Invasive Bladder Neoplasms""